Interactive Brokers Advertisement
Home > Boards > US OTC > Delisted >

Synova Healthcare Group Inc.(fka SNVHQ)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 10/1/2013 9:51:04 AM - Followers: 1 - Board type: Free - Posts Today: 0

Company Website Synova Healthcare, Inc. was incorporated in Delaware in April 2003, and is a wholly owned operating subsidiary of Synova Healthcare Group, Inc., a Nevada corporation. Since its inception, Synova Healthcare, Inc. has developed and distributed over-the-counter and point-of-care diagnostic tests that allow consumers and healthcare professionals to rapidly and accurately diagnose and/or monitor certain health conditions. Synova is committed to delivering high-quality and innovative medical diagnostics that are designed to assist consumers in being more proactive in the management of their personal health. Synova believes that early and accurate diagnosis will provide consumers, along with their healthcare providers, the ability to act to mitigate certain risks that may be inherent to certain conditions. The Company's goal, where possible, is to supplant traditional invasive diagnostic testing, like blood tests, by offering consumers and clinicians a quick and accurate, non invasive test at the very point where it's use is desired (either in-home or in-office). Synova's two current products, Menocheck® and MenocheckPro™ are in-home and in-office non-invasive urine FSH (Follicle-Stimulating Hormone) tests used for detecting and diagnosing the onset of menopause. Menocheck® is available at retail food and drug chains while MenocheckPro™ is available from physician/laboratory supply organizations for use by healthcare professionals. Both products are FDA approved. Synova is currently evaluating additional diagnostic product opportunities, including products that may prove useful in the areas of infertility, obstetrics and the detection of certain cancers. In some cases, Synova will own the intellectual property as part of the Company's product development strategy. CONTACT INFORMATION: Synova Healthcare Group, Inc. Robert Edwards Tel: 610-565-7080 The Investor Relations Group Investor Relations: Katrine Winther-Olesen Tel: 212-825-3210
Interactive Brokers Advertisement
#18   SNVHQ revoked: Renee 10/01/13 09:51:04 AM
#17   SNVHQ SEC Suspension: Renee 09/10/13 09:51:17 AM
#16   CHART: TOUCAN 02/21/10 01:47:28 PM
#13   have picked up a few shares below .01, calcul8r 01/06/08 06:54:32 AM
#12   wht goin on wit this???? momoneynow 01/04/08 01:44:39 PM
#11   out at .05, that was quick... good luck! RocknRoll 12/20/07 10:09:32 AM
#10   -------------------------------------------------------------------------------- investolator1 12/20/07 09:29:44 AM
#9   yes, that's why the drop from .30 to RocknRoll 12/19/07 09:16:25 PM
#8   in SNVH, .042 average... maybe they were bluffing RocknRoll 12/19/07 09:15:19 PM
#7   Chapter 11 filing!!!!! choctaw 12/19/07 09:13:17 PM
#6   now check this out, double ouch! RocknRoll 12/19/07 08:29:05 PM
#5   look at these recent insider acquisitions... ouch! RocknRoll 12/19/07 08:26:57 PM
#4   Should give us a bounce soon as most investolator1 12/19/07 02:47:56 PM
#3   11/21/07 0.510 0.500 0.500 0.600 3,070 RocknRoll 12/19/07 01:27:20 PM
#2   relatively low volume (900k) for a 90% drop RocknRoll 12/19/07 01:24:42 PM
#1   in at .045, lotto/bounce prospect ??? RocknRoll 12/19/07 01:22:41 PM